Freeline Therapeutics Holdings PlcEigentümerstruktur
| Preis (2024-02-16) | 52W Hoch | 52W Tief |
| 6.48 USD | 7,7 USD | 2,11 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 12,8 USD | 1 | 0 | 1 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 4.357.950 | 0,61 | 1,92 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Freeline Therapeutics Holdings Plc
Mitarbeiter 152
Handelsplatz NASDAQ
Ticker Symbol FRLN
IPO Datum 2020-08-07
Adresse Sycamore House, Stevenage, United Kingdom, SG1 2BP
Webseite https://www.freeline.life
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Michael J. Parini J.D. | CEO & Executive Director |
| 2 | Mr. Paul M. Schneider | CFO & Director |
| 3 | Dr. Henning R. Stennicke Ph.D. | Chief Scientific Officer |
| 4 | Ms. Nicole Jones SPHR | Chief People Officer |
| 5 | Mr. James Bircher | Chief Technical Operations Officer |
| 6 | Dr. Pamela Foulds M.D. | Chief Medical Officer |
| 7 | Ms. Naomi Aoki | Senior Vice President of Corporate Communications & Investor Relations |
| 8 | Ms. Amy J. Spandau | Interim Head of Finance |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | UBS Group AG | 0,00% | 0,00 Mio. USD |
| 2 | Blue Owl Capital Holdings LP | 0,00% | 0,00 Mio. USD |
| 3 | CHI Advisors LLC | 0,00% | 0,00 Mio. USD |
| 4 | JPMorgan Chase & Co | 0,00% | 0,00 Mio. USD |
| 5 | Penderfund Capital Management Ltd | 0,00% | 0,00 Mio. USD |
| 6 | Morgan Stanley - Brokerage Accounts | 0,00% | 0,00 Mio. USD |
| 7 | Renaissance Technologies Corp | 0,00% | 0,00 Mio. USD |
| 8 | Harbor Capital Advisors Inc | 0,00% | 0,00 Mio. USD |
| 9 | Sphera Funds Management Ltd. | 0,00% | 0,00 Mio. USD |
| 10 | Northern Trust Corp | 0,00% | 0,00 Mio. USD |
| 11 | Rhumbline Advisers | 0,00% | 0,00 Mio. USD |
| 12 | Gradient Investments | 0,00% | 0,00 Mio. USD |
| 13 | Aspire Private Capital, LLC | 0,00% | 0,00 Mio. USD |
| 14 | Qube Research & Technologies | 0,00% | 0,00 Mio. USD |
| 15 | Polygon Management Ltd | 0,00% | 0,00 Mio. USD |
| 16 | Millennium Management LLC | 0,00% | 0,00 Mio. USD |
| 17 | TANG CAPITAL MANAGEMENT LLC | 0,00% | 0,00 Mio. USD |